Clinical Trials Directory

Trials / Unknown

UnknownNCT00927771

Azelaic Acid Versus Hydroquinone in Melasma

Efficacy & Safety of Azelaic Acid 15% Gel vs. Hydroquinone 4% Cream in the Treatment of Melasma

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Callender Center for Clinical Research · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the safety and effectiveness of Azelaic Acid Gel to Hydroquinone Cream in the treatment of melasma.

Detailed description

Melasma is a chronic condition in which dark areas appear on the forehead, cheeks, and upper lips. Hydroquinone is a skin lightener (or fade cream) and is one of the most commonly used medications for the treatment of melasma. Azelaic acid gel is currently used to treat acne and rosacea.

Conditions

Interventions

TypeNameDescription
DRUGazelaic acid gelazelaic acid 15% gel twice a day for 6 months
DRUGhydroquinone creamhydroquinone 4% cream twice a day for 6 months

Timeline

Start date
2009-06-01
Primary completion
2010-06-01
Completion
2010-12-01
First posted
2009-06-25
Last updated
2009-06-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00927771. Inclusion in this directory is not an endorsement.